14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

CYTR Predictions History

6 years ago
bbullish2 predicted that CYTR for 2017-06-07 is going $0.677 (-78.48%)

6 years ago
AD predicted that CYTR for 2017-06-06 is going $0.631 (-80.85%)

Rank:

6 years ago
Vincent.Hebert.7729 predicted that CYTR for 2017-06-05 is going $1.21 (-75.41%)

Rank:

6 years ago
Bloodclot predicted that CYTR for 2017-06-05 is going $0.96 (-80.51%)

Rank:

6 years ago
JS predicted that CYTR for 2017-06-05 is going $0.80 (-83.68%)

6 years ago
Jon predicted that CYTR for 2017-06-05 is going $0.678 (-86.22%)

6 years ago
Allen.Gammel.7520 predicted that CYTR for 2017-06-05 is going $0.93 (-81.10%)

Rank:

6 years ago
JS predicted that CYTR for 2017-06-02 is going $0.84 (-82.97%)

6 years ago
JS predicted that CYTR for 2017-05-30 is going $0.760 (-82.65%)

6 years ago
JuanC Villegas predicted that CYTR for 2017-05-25 is going $0.496 (-83.61%)

Click to get the best stock tips daily for free!

About CytRx Corporation

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and A... CYTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT